Search Tag: Cancer
2024 13 Nov
Seriously ill patients and their families endure intense emotional suffering, which must be addressed through compassionate communication from clinicians as part of the treatment process. In a recent study published in Mayo Clinic Proceedings, researchers highlight specific “never words”—phrases that should never be used—and offer guidance...Read more
2024 21 Oct
Sepsis affects nearly 50 million people globally. Survivors face significant long-term issues like reduced quality of life and frequent hospital readmissions. Studies show that 21.4% of survivors are readmitted within 30 days and 39% by one year, with sepsis-related readmissions being costlier than those for other conditions like heart failure or myocardial...Read more
2024 18 Oct
Half of all patients admitted to an emergency department with sepsis died within two years, according to a Danish study aimed at identifying factors that could predict patient outcomes. These findings were presented at the European Emergency Medicine Congress. Study researchers analysed a cohort of 714 adult sepsis patients, revealing key risk...Read more
2024 30 Sep
A study using clinical trial data has identified a higher risk of stroke, heart attack, and hospitalisations for heart failure among older cancer survivors. Published in Cancer, the analysis also linked chemotherapy to increased rates of these cardiovascular conditions. While advancements in cancer treatments have reduced mortality rates over...Read more
2024 17 Sep
The RESILIENCE clinical trial aims to assess the safety and effectiveness of remote ischaemic conditioning (RIC) in preventing the cardiotoxic effects of anthracycline-based chemotherapy in lymphoma patients. This trial is expected to provide critical insights and potential solutions for a major clinical challenge. Anthracycline-induced cardiotoxicity...Read more
2024 03 Jun
A new study conducted by researchers from the Mass General Cancer Center shows that statins—commonly used cholesterol-lowering drugs—may inhibit a specific pathway in cancer development caused by chronic inflammation. The findings are published in Nature Communications. Chronic inflammation is a major cause of cancer worldwide. In this...Read more
2024 01 Jun
Numerous studies have reported the health benefits of the Mediterranean diet. However, long-term data on its effects have been limited, and the reasons behind its mortality risk reduction are not well understood. In a new study following over 25,000 initially healthy women in the U.S. for up to 25 years, researchers from Brigham and Women’s Hospital...Read more
2024 06 Feb
A recent report released by the International Agency for Research on Cancer (IARC) ahead of World Cancer Day sheds light on the escalating burden of cancer worldwide. According to fresh projections, the number of new cancer cases in Europe is anticipated to rise by 22.5 percent over the next twenty years. Globally, there is an estimated 55 percent...Read more
2024 06 Feb
A recent report released by the International Agency for Research on Cancer (IARC) ahead of World Cancer Day sheds light on the escalating burden of cancer worldwide. According to fresh projections, the number of new cancer cases in Europe is anticipated to rise by 22.5 percent over the next twenty years. Globally, there is an estimated 55 percent...Read more
2024 20 Jan
According to the National Cancer Institute , the incidence of cervical cancer in the United States has been steadily declining in recent decades, from an estimated 11.2 cases per 100,000 women in 1992 to 6.7 cases per 100,000 women in 2019. Statistics from other parts of the world, however, paint a substantially different picture. In the...Read more
2023 01 Dec
According to research published in JAMA Open, increasing use of recommended screening strategies could reduce the burden of cancer in the U.S. After conducting a decision analytical model study using simulation models of the natural history of cancer among U.S. residents, researchers observed a noteworthy outcome. A 10-percentage point...Read more
2023 01 Dec
According to research published in JAMA Open, increasing use of recommended screening strategies could reduce the burden of cancer in the U.S. After conducting a decision analytical model study using simulation models of the natural history of cancer among U.S. residents, researchers observed a noteworthy outcome. A 10-percentage point...Read more
2023 29 Nov
Verini to lead 80-year-old national nonprofit for people coping with cancer Cancer Care ®, the leading national nonprofit organization providing free, professional support services to anyone affected by cancer, announced the appointment of Christine Verini as its new Chief Executive Officer, effective December 1. This appointment is an integral...Read more
2023 02 Nov
The UK prime minister recently announced a new mission to accelerate the use of AI in life sciences to address today's major health challenges. This funding will be targeted towards areas that AI has the greatest potential to create breakthroughs in treatments, as well as exploring how AI could address conditions with some of the highest mortality...Read more
2023 19 Oct
A recent study looked at whether interventions can improve timely follow-up of overdue abnormal cancer screening results. The primary care intervention was multi-level comprising electronic health record reminders, patient outreach and navigation. Scientists evaluated this innovation through a randomised clinical trial conducted across...Read more
2023 28 Sep
In a recent report, published in the journal Cancer, researchers have documented a significant decline in cancer screenings and subsequent diagnoses in the United States during the initial stages of the Covid-19 pandemic. There were notable decreases in the number of newly diagnosed cases across six types of cancer including colorectal, female breast,...Read more
2023 19 Sep
Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases announced the appointment of Barbara J. Klencke, M.D., to its board of directors. Dr. Klencke has more than 20 years of biopharmaceutical product development experience, and she most recently served...Read more
2023 15 Sep
Paige, a healthcare technology disrupter, has partnered with Microsoft in the battle against cancer, advancing their joint efforts to transform cancer diagnosis and patient treatment. They aim to achieve this by constructing the world's largest image-based artificial intelligence (AI) model for digital pathology and oncology. Paige has developed...Read more
2023 07 Sep
Located in Warsaw, the capital of Poland, the Maria Skłodowska-Curie National Research Institute of Oncology is a leading centre for cancer research and treatment with over 85 years of distinguished tradition. A beacon of modern oncological care, the centre comprises 13 highly specialised departments, each dedicated to providing the highest level of...Read more
2023 07 Sep
Located in Warsaw, the capital of Poland, the Maria Skłodowska-Curie National Research Institute of Oncology is a leading centre for cancer research and treatment with over 85 years of distinguished tradition. A beacon of modern oncological care, the centre comprises 13 highly specialised departments, each dedicated to providing the highest level of...Read more
2023 05 Sep
Cancer and coronary diseases, infections and new anti-bacterial active substances, digitalisation and artificial intelligence – these are some of the top issues discussed this year at the MEDICA LABMED FORUM, which is part of the MEDICA 2023 trade fair in Düsseldorf. Over the last years, the forum has developed into an especially noted part of the...Read more
2023 04 Sep
Cancer Research UK has refreshed its branding with the aim of highlighting the tangible impact of its work on the lives of cancer patients, rather than solely focusing on the science. On September 1st, Cancer Research UK launched a campaign titled 'We Are'. This campaign shines a spotlight on the moments that cancer patients and former patients...Read more
2023 30 Aug
The scale of destruction wreaked on human life and happiness by cancer hardly needs any illustration. Significant disparities exist between countries, caused primarily by differences in national wealth and income. OncoSeek provides good accuracy in detection and diagnosis and will be a game-changing and life-saving multi-cancer early detection test....Read more
2023 30 Aug
The scale of destruction wreaked on human life and happiness by cancer hardly needs any illustration. Significant disparities exist between countries, caused primarily by differences in national wealth and income. OncoSeek provides good accuracy in detection and diagnosis and will be a game-changing and life-saving multi-cancer early detection test....Read more
2023 30 Aug
The scale of destruction wreaked on human life and happiness by cancer hardly needs any illustration. Significant disparities exist between countries, caused primarily by differences in national wealth and income. OncoSeek provides good accuracy in detection and diagnosis and will be a game-changing and life-saving multi-cancer early detection test....Read more
2023 09 May
As a leader in women’s health, Hologic knows that increasing access to breast cancer screening is critical to detecting cancer earlier and saving lives. We commend the U.S. Preventive Services Task Force (USPSTF) for changing their draft guidelines to recommend that women begin screening at age 40. Lowering the age for initial screening to 40...Read more
2023 11 Apr
A team of researchers, from the University of Utah, have published a study in the Journal of The National Cancer Institute Cancer Spectrum to demonstrate whether a large language model (LLM) ChatGPT can deliver accurate information related to cancer information and dispel common concerns. Given the importance of accurate information in the field...Read more
2023 15 Mar
Pfizer is deploying its financial resources to accelerate the battle against cancer, having signed a $43 billion agreement to buy cancer drugmaker Seagen. Their goal is to reach deeper into new cancers treatments. Seagen specialises in a type of cancer therapy known as an antibody-drug conjugate, and its key products use lab-made proteins, known...Read more
2023 15 Mar
Pfizer is deploying its financial resources to accelerate the battle against cancer, having signed a $43 billion agreement to buy cancer drugmaker Seagen. Their goal is to reach deeper into new cancers treatments. Seagen specialises in a type of cancer therapy known as an antibody-drug conjugate, and its key products use lab-made proteins, known...Read more